use of the products included in the recall may cause serious injuries or death
San Diego, CA (PRWEB) August 19, 2014
AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on IPM Wound Gel.
Wellspring Pharmaceutical Corporation announced on August 12, that one lot of IPM Wound Gel, distributed by Edwards Pharmaceuticals Inc., is being recalled due to microbial contamination. IPM wound gel is mainly used in hospitals for wound care.
The reason for the recall is that one lot of IPM Wound Gel may be contaminated with bacteria (Pseudomonas Putida). The affected lot number is Lot # 3P3446. The over-the-counter IPM Wound Gel is not included in this recall.
The FDA classified this recall as Class I, meaning use of the products included in the recall may cause serious injuries or death.
Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds “we are determined to keep an eye on FDA announcements concerning IPM Wound Gel and inform the public. For that reason", he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”
According to the announcement “Customers should return the affect products for destruction to the firm and notify any customers who received the product through redistribution.”
AttorneyOne.com has further information on IPM Wound Gel at the website including the latest major drug, medical products, and food law news.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/08/prweb12100590.htm